09:04 AM EDT, 08/18/2025 (MT Newswires) -- NanoViricides ( NNVC ) said Monday its NV-387 antiviral drug could help lower resurgence of metastatic cancer caused by awakening of "sleeping" cancer cells due to viral infections.

The biopharmaceutical company said the drug is being advanced into phase II trials following completion of a phase I trial.

Shares were up 2% in recent premarket activity.